Curie Bio Series A Fund I, L.P. — Form D/A
Curie Bio Series A Fund I, L.P. of CAMBRIDGE, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2024-06-26. The offering totals $376.7M, of which $376.7M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-06-26
- Form: D/A
- Accession: 0002009749-24-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $376.7M
- Amount sold: $376.7M
- Investors: 48
- Date of first sale: 2024-02-29
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-506345
Issuer
- Name: Curie Bio Series A Fund I, L.P.
- CIK: 0002009749
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 196 BROADWAY, 1ST FLOOR, CAMBRIDGE, MA, 02139
- Phone: 917-796-6472
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Alexis Borisy | Executive Officer | Boston, MA |
| N/A Curie Bio Investments, LLC | Executive Officer | Cambridge, MA |
| N/A Curie Bio, LLC | Executive Officer | Cambridge, MA |
| N/A Curie Bio Series A GP I, L.L.C. | Executive Officer | Cambridge, MA |
| Zachary Weinberg | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More